Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-25-008964

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 262.99 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-21 Grant or award : show line 1 in the form Deferred Stock Units +262.99 $10.53 $2,769 15,121.52 D
Loading xslF345X05/form4-03252025_110327.xml…